Herbalife Ltd. (NYSE:HLF) Receives Consensus Recommendation of “Hold” from Brokerages

Herbalife Ltd. (NYSE:HLF) has been given an average rating of “Hold” by the five analysts that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $9.90.

A number of brokerages recently commented on HLF. Citigroup cut their price target on Herbalife from $16.00 to $13.00 and set a “buy” rating for the company in a report on Friday, October 25th. Mizuho raised their target price on shares of Herbalife from $8.00 to $9.00 and gave the company a “neutral” rating in a report on Friday, November 1st. DA Davidson decreased their price target on shares of Herbalife from $13.00 to $7.50 and set a “neutral” rating on the stock in a research note on Thursday, October 31st. B. Riley dropped their price objective on shares of Herbalife from $17.00 to $12.00 and set a “buy” rating for the company in a research note on Thursday, October 31st. Finally, StockNews.com upgraded shares of Herbalife from a “hold” rating to a “buy” rating in a research report on Monday, November 4th.

Herbalife Stock Performance

Shares of NYSE:HLF opened at $5.45 on Friday. The firm has a market cap of $548.81 million, a price-to-earnings ratio of 6.41, a P/E/G ratio of 0.19 and a beta of 1.18. The firm has a fifty day moving average price of $6.93 and a 200 day moving average price of $7.83. Herbalife has a fifty-two week low of $5.41 and a fifty-two week high of $12.81.

Herbalife (NYSE:HLF) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.57 EPS for the quarter, beating the consensus estimate of $0.19 by $0.38. Herbalife had a net margin of 1.73% and a negative return on equity of 18.66%. The business had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.23 billion. As a group, research analysts predict that Herbalife will post 1.51 earnings per share for the current year.

Institutional Investors Weigh In On Herbalife

Several hedge funds and other institutional investors have recently made changes to their positions in HLF. Perpetual Ltd grew its holdings in Herbalife by 107.1% during the 4th quarter. Perpetual Ltd now owns 966,063 shares of the company’s stock valued at $6,463,000 after purchasing an additional 499,572 shares during the last quarter. Barclays PLC grew its stake in shares of Herbalife by 347.0% during the third quarter. Barclays PLC now owns 161,426 shares of the company’s stock valued at $1,160,000 after buying an additional 125,311 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Herbalife by 72.1% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 168,209 shares of the company’s stock valued at $1,209,000 after buying an additional 70,498 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of Herbalife by 6.9% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,479,957 shares of the company’s stock worth $17,831,000 after acquiring an additional 160,792 shares during the last quarter. Finally, Marshall Wace LLP boosted its holdings in Herbalife by 2,053.6% during the 2nd quarter. Marshall Wace LLP now owns 1,977,155 shares of the company’s stock valued at $20,543,000 after acquiring an additional 1,885,346 shares during the period.

About Herbalife

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.